VAL — ValiRx Cashflow Statement
0.000.00%
Last trade - 00:00- £1.78m
- -£0.17m
- £0.05m
Annual cashflow statement for ValiRx, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.65 | -1.68 | -2.59 | -2.3 | -2.14 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.155 | 0.185 | 0.54 | 0.037 | -0.03 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.645 | 0.004 | 0.129 | 0.235 | 0.32 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.91 | -1.26 | -1.71 | -1.77 | -1.58 |
| Capital Expenditures | -0.093 | 0 | — | -0.306 | -0.038 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.002 | 0 | 0 | — | — |
| Sale/Maturity of Investment | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.091 | 0 | 0 | -0.306 | -0.038 |
| Financing Cash Flow Items | -0.246 | 0 | -0.209 | -0.168 | -0.36 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.85 | 0.007 | 2.26 | 1.12 | 3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.85 | -1.25 | 0.544 | -0.963 | 1.38 |